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The latest data from the International Diabetes 
Federation[1] show that the prevalence of adults with 
type 2 diabetes mellitus (DM) is highest in low- and 
middle-income countries, with sub-Saharan Africa 
and the Indian subcontinent being highlighted as 
two of the regions where this rise will be the greatest. Earlier 
epidemiological studies[2,3] show that South African (SA) Indians have 
a high prevalence[2] and incidence[3] of DM. In the past two decades 
there have been major sociopolitical changes in these communities, 
and the lack of current data on the changes in cardiovascular (CV) risk 
profile and the emergence of premature coronary artery disease[4] was 
the rationale for a survey of the CV risk factor profile of SA Indians.
Objective
To determine the CV risk factor prevalence in a community-based 
sample of SA Indians.
Methods
Sampling
The Phoenix Lifestyle Project was a cross-sectional study conducted 
over a 2-year period (January 2007 - December 2008) on SA Indians 
aged 15 - 64 years residing in the Phoenix area (eThekwini Municipality, 
Durban, SA). This community forms a heterogeneous population of 
Dravidian and Aryan ancestry, and are mainly descendants of Indians 
who arrived in SA from 1860 as indentured labourers on the sugar 
plantations in Natal.[5]
Two-stage cluster sampling was used to select the households. 
First, a proportional representation of the number of households 
was selected from each area. Thereafter, the households to be studied 
in each area were randomly selected. One individual from each 
household was selected using the Kish method.[6] Fieldworkers were 
trained to follow a prescribed guideline using the Kish method of 
selection so that participants were stratified for age (15 - 24, 25 - 34, 
35 - 44, 45 - 54 and 55 - 64 years) and gender (male and female), with 
198 males and 198 females in each stratum.
Ethical considerations
The study was approved by the University of KwaZulu-Natal 
Bioethics Committee (ethics reference: E336/05) and conformed to 
the principles in the Declaration of Helsinki. All subjects gave written 
informed consent for the collection of the data and were informed of 
the results of the examinations undertaken. Subjects in whom risk 
factors were identified were referred to a health facility for further 
evaluation and management.
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Background. Previous studies show a high prevalence of cardiovascular (CV) risk factors in South African (SA) Asian Indians, with the 
emergence of premature coronary artery disease in young Indian subjects.
Objective. To determine the prevalence of CV risk factors in this population.
Methods. This was a cross-sectional study of randomly selected adults aged 15 - 64 years from the suburb of Phoenix in Durban, KwaZulu-Natal 
Province, SA. All participants had demographic, anthropometric and biochemical measurements using the modified World Health Organization 
(WHO) STEPwise survey methods. Hypertension, obesity, lipid abnormalities and diabetes mellitus (DM) were diagnosed using WHO criteria. 
Age-standardised frequencies for glycaemic indices were calculated according to the WHO standard world population distribution.
Results. Of the 1 428 subjects who responded (response rate 72.1%), complete data for analysis were available on 1 378 (1 001 women). The 
mean age was 45.5 (standard deviation 13) years. There were high prevalences of hypertension (47.5%), DM (20.1%), total body obesity 
(raised body mass index) (32.4%) and increased waist circumference (73.1%). The ‘thin-fat’ Asian phenotype (isolated abdominal obesity) 
was found in only 4.8% of participants. High prevalences of total body obesity (32.1%), increased waist circumference (31.3%) and insulin 
resistance (28.2%) were documented in the youngest age group. Over half of the males and 14.6% of females were current smokers. Diabetic 
dyslipidaemia was found in 61 subjects (4.4%). In multivariate analysis, age, triglycerides and waist circumference measurement were 
significant independent risk factors associated with DM and, together with fasting glucose, also predicted hypertension.
Conclusion. Compared with Asian Indian subjects with similar environmental exposure in previous studies, the magnitude of change in 
risk factor prevalence over the past two decades has been of epidemic proportions.
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Data collection
The World Health Organization (WHO) modified STEPS question-
naire for non-communicable disease risk factors (version 1.4 
questionnaire)[7] was used to record the demographic (including 
age, sex, education and income level) information and behavioural 
measurements at the participants’ homes. Other information included 
type of diet, physical activity, smoking habits, alcohol consumption 
and a personal and family (first-degree relatives) history of DM, 
hypertension and CV risk factors.
The clinical examination and investigations were performed at 
the Lifestyle Centre, Inkosi Albert Luthuli Central Hospital, Durban. 
Anthropometric measurements performed included height, weight 
and waist circumference according to WHO criteria.[7] Venous blood 
samples were taken after an overnight fast for measurement of plasma 
glucose, serum insulin and serum lipid (total cholesterol, high-
density lipoprotein (HDL) cholesterol and total triglyceride) levels. 
Fasting plasma glucose was measured using the glucose oxidase 
method and plasma insulin was measured by immunoassay. A 75 g 
oral glucose tolerance test (OGTT) was performed on participants 
who did not self-report a positive history of DM, for fasting and 
2-hour plasma glucose levels. Blood pressure (BP) was recorded on 
three occasions at 2-minute intervals and the average of the three 
readings was documented.
Definition and classification of CV risk factors
Anthropometry
Based on the body mass index (BMI), participants were classified as of 
normal weight (18.50 - 24.99 kg/m2), overweight (≥25 - 29.99 kg/m2) 
or obese (≥30 kg/m2). The revised cut-off point for Asian Indians[8] 
was also applied, i.e. subjects with a BMI <23 kg/m2 were classified 
as normal, those with a BMI of 23.0 - 24.9 kg/m2 as overweight 
and those with a BMI of ≥25.0 kg/m2 as obese. The prevalence of 
the ‘thin-fat Asian phenotype’ was also determined in subjects with 
isolated abdominal obesity, i.e. Asian criteria for waist circumference 
(men >90 cm, women >80 cm) and a normal BMI (<23 kg/m2).
Hypertension
Individuals who self-reported previously diagnosed hypertension, 
and/or those with blood pressure readings ≥140 and ≥90 mmHg 
(average of three readings) (Joint National Committee VII (JNC VII) 
criteria) and/or those on current antihypertensive therapy[9] were 
defined as having systemic hypertension. Using JNC VII guidelines, 
individuals with a systolic blood pressure of 120 - 139 mmHg or a 
diastolic blood pressure of 80 - 89 mmHg[9] were classed as having 
prehypertension.
Biochemistry
Lipid parameters were classified using criteria of the National 
Cholesterol Adult Panel III guidelines:[10] serum total cholesterol 
>5.17  mmol/L, serum total triglyceride >1.69 mmol/L, HDL 
cholesterol <1.04 mmol/L (men) and <1.29 mmol/L (women), 
and low-density lipoprotein (LDL) cholesterol >2.59 mmol/L. LDL 
cholesterol was calculated using the Friedewald equation. Diabetic 
dyslipidaemia was diagnosed if raised levels of LDL cholesterol and 
triglycerides, as well as low levels of HDL cholesterol, were present.
The WHO criteria[11] were used to classify glycaemic categories 
based on fasting plasma glucose (FPG): DM if the FPG was 
≥7.0  mmol/L, and impaired fasting glucose (IFG) if the FPG was 
≥6.1 and ≤6.9 mmol/L. Impaired glucose tolerance was defined if the 
FPG was <7.0 mmol/L and the 2-hour plasma glucose level during 
the OGTT was ≥7.8 and <11.1 mmol/L. Subjects with IFG or IGT 
were classified as having prediabetes. Homeostatic model assessment 
for insulin resistance (HOMA-IR) values were calculated using the 
formula: fasting insulin (µU/m) × fasting glucose (mmol/L)/22.5. 
Insulin resistance was defined as a HOMA-IR value of >2.6.[12] The 
age-standardised frequencies for glycaemic indices were calculated 
according to the WHO standard world population distribution.
Statistical analysis
Statistical analysis was performed using the SPSS programme 
(version 22, SPSS, USA). The distributional properties for all variables 
were investigated, and variables with a skewed distribution were log-
transformed or analysed using non-parametric testing. Means and 
standard deviations (SDs) and median values with interquartile 
ranges for non-Gaussian distributed variables were calculated for 
continuous variables. Categorical data were presented as percentages 
with corresponding 95% confidence intervals (CIs); the χ2 test was 
used for intergroup comparisons. For continuous variables, analysis 
of variance was used. Post-hoc analysis of variance comparisons for 
continuous variables was based on the Bonferroni correction.
Logistic regression (stepwise, backward) was used to identify risk 
factors associated with DM and hypertension. A p-value of <0.05 was 
regarded as being statistically significant.
Results
Of 1 980 participants selected, 1 428 individuals (402 males, 1 026 
females) participated in the study, giving a response rate of 72.1%. 
Non-responders were mainly males (40.6%, 402/990 male participants 
selected), with participation being higher in the older age groups. 
Complete data on all variables were available on 1 378 participants, 
who formed the study group for further analysis shown in Table 1. 
The majority of respondents were women (n=1 001, 72.6%), under-
represented in the 15 - 34-year age groups and over-represented in 
the 35 - 64-year age groups (Table 1).
The mean age of the total sample was 45.5 (SD 13) years, with the 
highest proportion of subjects in the 45 - 54-year age group (30.7%) 
(Table 2). The general pattern for blood pressure and biochemical 
variables among both males and females was an increase with 
advancing age. Participants in all age groups reported a positive 
family history for one or more of the following conditions: obesity, 
DM, hypertension, myocardial infarction (MI), stroke and heart 
failure (congestive heart failure (CHF), with hypertension being the 
most frequently reported (71.2%).
CV and metabolic risk factors in the sample
The most frequent abnormality was adiposity, both total (BMI) 
and central obesity (waist circumference) (Table 3). Almost one-
third were classified as obese (32.4%) or overweight (32.0%), 
with the prevalence increasing with age (p-trend <0.001). Using 
Asian cut-points, the prevalence of obesity doubled to 64.5%, and 
was significantly higher in women (71.0%) than in men (44.5%) 
Table 1. Age and gender distribution of study subjects
Age group (years)
Total,
n (%)
Males,
n (%)
Females,
n (%)
15 - 24 131 (9.5) 54 (41.2) 77 (58.8)
25 - 34 161 (11.6) 60 (37.3) 101 (62.7)
35 - 44 295 (21.4) 68 (23.1) 227 (76.9)
45 - 54 423 (30.7) 81 (20.1) 342 (80.9)
55 - 64 368 (26.7) 114 (30.9) 254 (69.0)
Total 1 378 377 (27.3) 1 001 (72.6)
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(p<0.001); of interest, almost a third of the participants (32.1%) in the 
25 - 34-year age groups were also obese. Isolated abdominal obesity 
using the Asian cut-points for waist circumference and a normal BMI 
(the ‘Asian phenotype’) was recorded in only 4.8% of the sample.
Almost half (47.5%) of the total group had hypertension, with the 
prevalence higher in women than in men (p<0.001) and increasing 
with age (p<0.001); the peak prevalence was in the oldest age groups. 
Prehypertension was found in 17.1% (n=236) of participants, and was 
more common in men than in women.
The crude prevalence of DM, including subjects who self-
reported, was 32.0%; the prevalence using WHO criteria was 27.4% 
(age-adjusted 20.1%), being higher in women (p<0.001) and with 
advancing age (p-trend <0.001). Prediabetes (IFG or IGT) was found 
in 29.1% of individuals (age-adjusted 17.6%) and IFG in 14.4% 
(age-adjusted 8.0%); the prevalence of impaired fasting glucose was 
also higher with advancing age (p-trend <0.001), with a peak in the 
55 - 64-year age group. Insulin resistance (HOMA-IR) was found in 
55.5% of participants (age-adjusted 49.6%); surprisingly, 36.6% (age-
adjusted 28.2%) of the participants in the youngest age group (15 - 24 
years) were also so classified (Table 3).
Hypercholesterolaemia was found in 57.0% of subjects, hyper-
triglyceridaemia in 42.2% and raised LDL cholesterol in 23.7%. 
A low concentration of HDL cholesterol was found in 43.3% of 
subjects, especially in women (48.1%) as opposed to men (30.1%). 
Of note is that even in the 15 - 24-year age group, 12.9% had elevated 
triglyceride levels and 35.1% had low HDL cholesterol levels. Diabetic 
dyslipidaemia (a combination of elevated triglycerides and LDL 
cholesterol, as well as low HDL cholesterol) was found in 4.4% of the 
sample, the prevalence being higher in men (6.6%) than in women 
(3.6%). Of the subjects 52.3% of males and 14.6% of females were 
current smokers, the figure for subjects in the 15 - 24-year age group 
being 26.7%.
Risk factor analysis
Age, total serum cholesterol, serum triglyceride, HDL cholesterol, 
waist circumference, BMI, blood pressure, smoking and HOMA 
values were used in a bivariate analysis for DM and hypertension. 
The BMI, blood pressure, smoking and HOMA values were not 
significant on bivariate analysis, and were subsequently excluded 
from the logistic regression model. In multiple logistic regression 
analysis, age, total serum cholesterol, serum triglyceride, HDL 
cholesterol and waist circumference were entered into the predictive 
model. The significant independent risk factors associated with 
DM included age, waist circumference and serum triglyceride. For 
hypertension, the same risk factors were independent predictors with 
the addition of fasting plasma glucose (Table 4). 
Discussion
This is the first study of SA Indians to document an extremely high 
CV risk factor prevalence, and it highlights the evolving epidemic 
of CV risk in teenagers and young adults in this population. Asian 
Indians across the diaspora are known to have high CV risk.[13] A 
previous diabetes epidemiology study reported over 20 years ago in 
the greater Durban area showed lower prevalences of hypertension 
(14%) and DM (13%).[2] Our study shows that the magnitude of 
change over two decades has been of epidemic proportions in 
subjects with similar environmental exposure.
The prevalences of hypertension (47.5%) and DM (age-
standardised 20.1%), in particular, are also strikingly high when 
compared with other population groups in SA. Stewart et al.[14] 
reported a 33% prevalence of hypertension and a 5% prevalence of 
DM in their Soweto cohort (black African), with a 28% prevalence of 
DM in the coloured community.[15]
Furthermore, the high number of participants who were currently 
smoking, particularly in the youngest age group, is concerning since 
these individuals already had multiple risk factors in the presence of 
smoking, which is known to exert a detrimental multiplicative effect 
on CV risk.[16]
Our study shows a high prevalence of hypercholesterolaemia 
(57%), raised triglyceride levels (42.2%), raised LDL cholesterol 
levels (23.7%) and low HDL cholesterol levels (43.3%). The low HDL 
cholesterol and raised triglyceride levels are in keeping with the 
characteristic dyslipidaemia pattern seen in Asian Indians, which 
together with the ‘thin-fat Asian phenotype’ (low BMI and raised 
waist circumference) is thought to contribute to the development of 
excess CVD in this population group.[17] Our findings are in direct 
contrast to this concept, since most of our subjects had generalised 
(both abdominal and total body) obesity. This, together with the 
emergence of multiple CV risk factors, including atherogenic 
dyslipidaemia, in the younger age group, predicts early onset of 
coronary heart disease[4] and is likely to impose a greater burden of 
CV disease in the near future, as these individuals reach adulthood.
Study strengths and limitations
The study is limited by its cross-sectional design, which rendered us 
unable to observe or to report on trends associated with CV events 
that could have developed over time. Another limitation was the 
low response rates of male participants, which means that the data 
on men should be interpreted with caution; however, this has been 
reported in other SA population studies.[14,15] In addition, limited 
participation was noted in the younger age groups, introducing a 
potential selection bias for non-working participants. The strength of 
this study is that it was a population-based study that also included 
a small sample of younger individuals and was able to show that CV 
risk was significantly high in this age group.
Conclusion
The extremely high prevalence of risk factors in our study explains 
the emergence of premature coronary heart disease in the community 
studied and calls for urgent and aggressive intervention measures 
aimed at diet, physical activity and cessation of smoking at schoolgoing 
level. A longitudinal follow-up study of these participants to ascertain 
the degree of CV risk associated with the marked changes in 
phenotype is urgently required.
Table 4. Logistic regression model for risk factors associated 
with diabetes mellitus and hypertension
Variable B Wald p-value OR 95% CI
Diabetes
Waist (cm) 0.016 12.8 <0.001 1.02 1.007 - 1.026
Tg (mmol/L) 0.576 61.1 <0.001 1.80 1.11 - 1.59
Age 0.02 5.125 <0.005 1.06 1.044 - 1.070
Hypertension
Waist (cm) 0.037 60 <0.001 1.04 1.03 - 1.047
FBG (mmol/L) 0.017 20.8 <0.001 1.02 1.069 - 1.081
Tg (mmol/L) 0.162 8.028 0.05 1.18 1.01 - 1.4
Age 0.070 133 <0.001 1.07 1.06 - 1.086
B = used to predict the dependent variable from the independent variable and presented 
in log-odds units; Wald statistic = used to assess the significance of the coefficients and 
contribution of individual predictors in a given model; Waist = waist circumference; 
Tg = triglyceride; FBG = fasting blood glucose.
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